Angioedema occurring in pediatric patients with Crohn disease treated with adalimumab.
Adamiak
Tonya
T
From the Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Stephens
Michael
M
Werlin
Steven L
SL
D000068879:Adalimumab; D000293:Adolescent; D000799:Angioedema / Q000139:chemically induced*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab